Telesis Bio, Inc. reported impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company reported goodwill impairment of $11,389,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.215 USD | +1.57% | -23.47% | -41.31% |
May. 09 | Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M | MT |
May. 09 | Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.31% | 7.05M | |
+12.06% | 227B | |
+12.07% | 192B | |
+13.88% | 136B | |
+27.12% | 108B | |
+0.76% | 64.07B | |
+13.39% | 52.1B | |
+6.74% | 51.87B | |
+8.81% | 44.33B | |
+4.14% | 36.75B |
- Stock Market
- Equities
- TBIO Stock
- News Telesis Bio, Inc.
- Telesis Bio, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023